You are here

reimbursement

Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement

Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement

Motley Fool

Flag link:

New Antibiotics Face Major Development And Reimbursement Hurdles

New Antibiotics Face Major Development And Reimbursement Hurdles

Forbes

antibiotic resistance

drug-resistant infections

drug development

Flag link:

Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles

Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles

Fierce Pharma

drug manufacturing

Bristol-Myers Squibb

Sarepta Therapeutics

Gilead Sciences

Flag link:

Drugs firms make massive discounts to get reimbursement in China

Drugs firms make massive discounts to get reimbursement in China

Pharmaforum

Flag link:

How Medical Billing Coverage Spells Success Or Failure For Drugmakers

How Medical Billing Coverage Spells Success Or Failure For Drugmakers

Motley Fool

Flag link:

Senate, White House hoping for deal to restructure Medicare drug payments

Senate, White House hoping for deal to restructure Medicare drug payments

BioCentury

Flag link:

Medicare proposes raising CAR-T pay, but reimbursement solution years away

Medicare proposes raising CAR-T pay, but reimbursement solution years away

Biopharma Dive

Flag link:

ICER's Growing Impact On Drug Pricing And Reimbursement

ICER's Growing Impact On Drug Pricing And Reimbursement

Forbes

Flag link:

China proposes 50% reimbursement for chronic disease therapies

China proposes 50% reimbursement for chronic disease therapies

BioCentury

chronic disease

Flag link:

What Will Keep Medtech up at Night in 2019?

What Will Keep Medtech up at Night in 2019?

Medical Devices and Diagnostics Industry

Flag link:

Hospital docs weigh in on CAR-T reimbursement: 'It's very complicated'

Hospital docs weigh in on CAR-T reimbursement: 'It's very complicated'

BioSpace

Flag link:

CMS rule cuts reimbursement for new Part B drugs

CMS rule cuts reimbursement for new Part B drugs

BioCentury

Medicare Part B

physician-administered drugs

Flag link:

Reimbursement lags cancer drug approvals, but some European countries wait longer

Reimbursement lags cancer drug approvals, but some European countries wait longer

Biopharma Dive

Flag link:

Better U.S. Patient Access To Cancer Drugs Comes At A Price

Better U.S. Patient Access To Cancer Drugs Comes At A Price

Forbes

Flag link:

Medicare sets outpatient rate for Yescarta reimbursement

Medicare sets outpatient rate for Yescarta reimbursement

Reuters

Gilead Sciences

Flag link:

Medical device reimbursement: How it’s a brave new world

Medical device reimbursement: How it’s a brave new world

Medical Design and Outsourcing

Flag link:

Reimbursement Trends for Medical Devices in Japan

Reimbursement Trends for Medical Devices in Japan

Medical Devices and Diagnostics Industry

Flag link:

Medical Device Reimbursement in the US

Medical Device Reimbursement in the US

RAPS.org

Flag link:

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

Drug Channels

Flag link:

Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?

Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?

Fierce Pharma

Flag link:

Pages